Omics-based Predictors of NAFLD/Potential NASH

Prof.Dr. Ammal Mokhtar Metwally, Prof. Public Health and Community Medicine

In: Ahmed MH, Noor SK, Bushara SO, Husa NE, Elmadhoun WM, Gaw, Osman MM, Mahmoud AO, Almobarak AO. Non-Alcohol Fatty Ler Dease Afra and Mdle East: An Attempt to Predt the Present and Future platns on the Healthcare System. Gastroenterology Res. 2017 Oct;10(5):271-279. do 10.14740/gr913w. Epub 2017 Oct 26. Gan L, ChturS, Farrell GC. Mechanms and platns of age-related changes the ler: nonalcohol Fatty ler dease the elderly. Curr Gerontol Gertr Res. 2011;2011:831536. do 10.1155/2011/831536. Epub 2011 Sep 12. Perakak N, Stefanak K, Mantzoros CS. The role of oms the pathophyslogy, dgnos and treatment of non-alcohol fatty ler dease. Metabolm. 2020 Oct;111S:154320. do 10.1016/j.metabol.2020.154320. Epub 2020 Jul 23. GaudPJ, Stephenson AM, TellC, Rosso N. Novel hh-throughput applatns for NAFLD dgnosts and bmarker dcovery. Hepatoma Res 2021; 7:2 Patel K, SebastnG. Latns of non-vase tests for assessment of ler fros. JHEP Rep. 2020 Jan 20;2(2):100067. do 10.1016/j.jhepr.2020.100067. eCollectn 2020 Apr. Beatt M, Dhawan A, Punt JWL, et al., Non alcohol fatty ler dease, chapter 61;520-528 Oxford Speclt Handbook of Paedtr Gastroenterology, Hepatology, and nutrn. Oxford unersy press, 3rd edn,2018 Rosenbaum J, Usyk M, Chen Z, Zoln CP, Jones HE, Waldron L, Dowd JB, Thorpe LE, Burk RD. Evaluatn of Oral Cavy DNA Extractn Methods on Bacterl and Fungal Mrobta. ScRep. 2019 Feb 6;9(1):1531. do 10.1038/s41598-018-38049-6. YounossZM, Reyes MJ, Mhra A, Mehta R, Henry L. Systemat revw wh meta-analys: non-alcohol steatohepat - a case for personaled treatment based on pathogen targets. Alent Pharmacol Ther. 2014 Jan;39(1):3-14. do 10.1111/apt.12543. Epub 2013 Nov 10. Commtee on the Revw of Oms-Based Tests for Predtg Patnt Outcomes Clal Trls; Board on Health Care Serves; Board on Health Scnces Poly; stute of Mede; Mheel CM, Nass SJ, Omenn GS, edors. Evolutn of Translatnal Oms: Lessons Learned and the Path Forward. Washgton (DC): Natnal Academs Press (US); 2012 Mar 23. Avaable from http://www.ncbnlm.n.gov/books/NBK202168/ X S, Zhan Q, Chen X, Xu J, Yu Y. Effacy of serum mNA test as a non-vase method to dgnose nonalcohol steatohepat: a systemat revw and meta-analys. BMC Gastroenterol. 2020 Jun 12;20(1):186. do 10.1186/s12876-020-01334-8. de Haan N, Falck D, Wuhrer M. Monorg of munoglobul N- and O-glycosylatn health and dease. Glycoblogy. 2020 Mar 20;30(4):226-240. do 10.1093/glycob/cwz048. Neuman MG, Cohen LB, Nanau RM. Bmarkers nonalcohol fatty ler dease. Can J Gastroenterol Hepatol. 2014 Dec;28(11):607-18. do 10.1155/2014/757929. LeonS, TovolF, NapolL, Ser FerrS, BolondL. Current gueles for the management of non-alcohol fatty ler dease: A systemat revw wh comparate analys. World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. do 10.3748/wjg.v24.0.3361. Vajro P, Lenta S, Socha P, Dhawan A, McKrnan P, Baumann U, Durmaz O, Lacale F, McL V, NobV. Dgnos of nonalcohol fatty ler dease chdren and adolescents: posn paper of the ESPGHAN Hepatology Commtee. J Pedtr Gastroenterol Nutr. 2012 May;54(5):700-13. do 10.1097/MPG.0b013e318252a13f. Chow, S.C.; Shao, J.; Wang, H. 2003. Sample Se Calculatns Clal Research. Marcel Dekker. New York. Cheah MC, McCullough AJ, Goh GB. Current Modals of Fros Assessment Non-alcohol Fatty Ler Dease. J Cl Transl Hepatol. 2017 Sep 28;5(3):261-271. do 10.14218/JCTH.2017.00009. Epub 2017 Jun 24. Castera L, Frdrh-Rust M, Loomba R. Nonvase Assessment of Ler Dease Patnts Wh Nonalcohol Fatty Ler Dease. Gastroenterology. 2019 Apr;156(5):1264-1281.e4. do 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18. Newby PK, Hu FB, Rm EB, Smh-Warner SA, Feskanh D, Sampson L, Wlett WC. Reproducy and valy of the Dt Qualy dex Reved as assessed by use of a food-frequency questnnae. Am J Cl Nutr. 2003 Nov;78(5):941-9. do 10.1093/ajcn/78.5.941. Matsuda K. PCR-Based Detectn Methods for Sgle-Nucleote Polymorphm or Mutatn: Real-Te PCR and s Substantl Contrutn Toward Technologal Refement. Adv Cl Chem. 2017;80:45-72. do 10.1016/bs.acc.2016.11.002. Epub 2017 Jan 4. PaparE, Noruz M, KashanL, Foster WG. entatn of candate mroRNA markers of endometrs wh the use of next-generatn sequencg and quantate real-te polymerase cha reactn. Fert Ster. 2020 Jun;113(6):1232-1241. do 10.1016/j.fertnstert.2020.01.026. Omics-based Predictors of NAFLD/Potential NASH: A New Era Towards Valid and Reliable Non-invasive Diagnosis and Personalized Therapy; S. 2020

Online report

Wie komme ich dran?

Zugriff:

View record in ClinicalTrials.gov (Volltext)

Titel:	Omics-based Predictors of NAFLD/Potential NASH
Autor/in / Beteiligte Person:	Prof.Dr. Ammal Mokhtar Metwally, Prof. Public Health and Community Medicine
Link:	View record in ClinicalTrials.gov (Volltext)
Quelle:	Ahmed MH, Noor SK, Bushara SO, Husa NE, Elmadhoun WM, Gaw, Osman MM, Mahmoud AO, Almobarak AO. Non-Alcohol Fatty Ler Dease Afra and Mdle East: An Attempt to Predt the Present and Future platns on the Healthcare System. Gastroenterology Res. 2017 Oct;10(5):271-279. do 10.14740/gr913w. Epub 2017 Oct 26. Gan L, ChturS, Farrell GC. Mechanms and platns of age-related changes the ler: nonalcohol Fatty ler dease the elderly. Curr Gerontol Gertr Res. 2011;2011:831536. do 10.1155/2011/831536. Epub 2011 Sep 12. Perakak N, Stefanak K, Mantzoros CS. The role of oms the pathophyslogy, dgnos and treatment of non-alcohol fatty ler dease. Metabolm. 2020 Oct;111S:154320. do 10.1016/j.metabol.2020.154320. Epub 2020 Jul 23. GaudPJ, Stephenson AM, TellC, Rosso N. Novel hh-throughput applatns for NAFLD dgnosts and bmarker dcovery. Hepatoma Res 2021; 7:2 Patel K, SebastnG. Latns of non-vase tests for assessment of ler fros. JHEP Rep. 2020 Jan 20;2(2):100067. do 10.1016/j.jhepr.2020.100067. eCollectn 2020 Apr. Beatt M, Dhawan A, Punt JWL, et al., Non alcohol fatty ler dease, chapter 61;520-528 Oxford Speclt Handbook of Paedtr Gastroenterology, Hepatology, and nutrn. Oxford unersy press, 3rd edn,2018 Rosenbaum J, Usyk M, Chen Z, Zoln CP, Jones HE, Waldron L, Dowd JB, Thorpe LE, Burk RD. Evaluatn of Oral Cavy DNA Extractn Methods on Bacterl and Fungal Mrobta. ScRep. 2019 Feb 6;9(1):1531. do 10.1038/s41598-018-38049-6. YounossZM, Reyes MJ, Mhra A, Mehta R, Henry L. Systemat revw wh meta-analys: non-alcohol steatohepat - a case for personaled treatment based on pathogen targets. Alent Pharmacol Ther. 2014 Jan;39(1):3-14. do 10.1111/apt.12543. Epub 2013 Nov 10. Commtee on the Revw of Oms-Based Tests for Predtg Patnt Outcomes Clal Trls; Board on Health Care Serves; Board on Health Scnces Poly; stute of Mede; Mheel CM, Nass SJ, Omenn GS, edors. Evolutn of Translatnal Oms: Lessons Learned and the Path Forward. Washgton (DC): Natnal Academs Press (US); 2012 Mar 23. Avaable from http://www.ncbnlm.n.gov/books/NBK202168/ X S, Zhan Q, Chen X, Xu J, Yu Y. Effacy of serum mNA test as a non-vase method to dgnose nonalcohol steatohepat: a systemat revw and meta-analys. BMC Gastroenterol. 2020 Jun 12;20(1):186. do 10.1186/s12876-020-01334-8. de Haan N, Falck D, Wuhrer M. Monorg of munoglobul N- and O-glycosylatn health and dease. Glycoblogy. 2020 Mar 20;30(4):226-240. do 10.1093/glycob/cwz048. Neuman MG, Cohen LB, Nanau RM. Bmarkers nonalcohol fatty ler dease. Can J Gastroenterol Hepatol. 2014 Dec;28(11):607-18. do 10.1155/2014/757929. LeonS, TovolF, NapolL, Ser FerrS, BolondL. Current gueles for the management of non-alcohol fatty ler dease: A systemat revw wh comparate analys. World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. do 10.3748/wjg.v24.0.3361. Vajro P, Lenta S, Socha P, Dhawan A, McKrnan P, Baumann U, Durmaz O, Lacale F, McL V, NobV. Dgnos of nonalcohol fatty ler dease chdren and adolescents: posn paper of the ESPGHAN Hepatology Commtee. J Pedtr Gastroenterol Nutr. 2012 May;54(5):700-13. do 10.1097/MPG.0b013e318252a13f. Chow, S.C.; Shao, J.; Wang, H. 2003. Sample Se Calculatns Clal Research. Marcel Dekker. New York. Cheah MC, McCullough AJ, Goh GB. Current Modals of Fros Assessment Non-alcohol Fatty Ler Dease. J Cl Transl Hepatol. 2017 Sep 28;5(3):261-271. do 10.14218/JCTH.2017.00009. Epub 2017 Jun 24. Castera L, Frdrh-Rust M, Loomba R. Nonvase Assessment of Ler Dease Patnts Wh Nonalcohol Fatty Ler Dease. Gastroenterology. 2019 Apr;156(5):1264-1281.e4. do 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18. Newby PK, Hu FB, Rm EB, Smh-Warner SA, Feskanh D, Sampson L, Wlett WC. Reproducy and valy of the Dt Qualy dex Reved as assessed by use of a food-frequency questnnae. Am J Cl Nutr. 2003 Nov;78(5):941-9. do 10.1093/ajcn/78.5.941. Matsuda K. PCR-Based Detectn Methods for Sgle-Nucleote Polymorphm or Mutatn: Real-Te PCR and s Substantl Contrutn Toward Technologal Refement. Adv Cl Chem. 2017;80:45-72. do 10.1016/bs.acc.2016.11.002. Epub 2017 Jan 4. PaparE, Noruz M, KashanL, Foster WG. entatn of candate mroRNA markers of endometrs wh the use of next-generatn sequencg and quantate real-te polymerase cha reactn. Fert Ster. 2020 Jun;113(6):1232-1241. do 10.1016/j.fertnstert.2020.01.026. Omics-based Predictors of NAFLD/Potential NASH: A New Era Towards Valid and Reliable Non-invasive Diagnosis and Personalized Therapy; S. 2020
Medientyp:	report
Sonstiges:	Nachgewiesen in: ClinicalTrials.gov Sprachen: English

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.